Innoviva (INVA) Shares Outstanding (2009 - 2026)

Innoviva (INVA) reported Shares Outstanding of $73.8 million for Q1 2026, up 17.58% on a YoY basis from $62.8 million in Q1 2025, and down 1.11% quarter-over-quarter from $74.6 million in Q4 2025.

Innoviva (INVA) Shares Outstanding (2009 - 2026) Analysis & Trends

Innoviva has reported Shares Outstanding for 18 years, with the latest figure at $73.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding rose 17.58% year-over-year to $73.8 million; the trailing twelve-month figure through Mar 2026 stood at $73.8 million (up 17.58% YoY), and the FY2025 full-year result was $74.6 million, up 19.1% from the prior year.
  • Shares Outstanding for Q1 2026 stood at $73.8 million, down from $74.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $74.8 million in Q3 2025, with the low at $69776.0 in Q3 2022.
  • Historically, Shares Outstanding has averaged $56.4 million across 5 years, with a median of $62.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding tumbled 99.9% — and 2023, when it soared 92172.41%.
  • Innoviva's Shares Outstanding stood at $69.2 million in 2022, then dropped by 8.5% to $63.3 million in 2023, then decreased by 1.01% to $62.7 million in 2024, then climbed by 19.1% to $74.6 million in 2025, then slipped by 1.11% to $73.8 million in 2026.
  • The last three Shares Outstanding figures came in at $73.8 million (Q1 2026), $74.6 million (Q4 2025), and $74.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 91.57 Bn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1.88
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 254.16 Mn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn 73.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Mar 31, 2026 73.81 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Dec 31, 2025 74.64 Mn
Sep 30, 2025 74.77 Mn
Sep 30, 2025 74.77 Mn
Sep 30, 2025 74.77 Mn
Sep 30, 2025 74.77 Mn